Biohaven Pharmaceuticals, Inc

Biohaven Pharmaceuticals, Inc: Commercial-stage, focused on neurological & neuropsychiatric diseases; CGRP receptor antagonist, glutamate modulation, and MPO platforms. NURTECĀ® ODT approved 1Q20 (acute treatment of migraine); $93m 2Q20 revenues. NURTEC ODT preventive treatment of migraine sNDA filing accepted by FDA; PDUFA date May 2021. 4Q21 exp. Ph 3 MSA readout.
Based in...
US - New England
Clinical Stage
Phase III
Disease Space
Central Nervous System, Rare Disease
Public, USA
Market Cap
1B +
Therapeutic Modalities
Small Molecule
215 Church Street
New Haven, CT 06510
United States

Company Participants at Hamptons CEO Roundtable 2019

  • Vlad Coric, M.D., Chief Executive Officer

Upcoming Company Event Participation

Top 10 Holders of Biohaven Pharmaceutical Holding Company Ltd.

Institution OS (%) Position Mkt Val ($MM) Source Filing Date
Capital Research & Management Co. (Global Investors) 11.22 7,291,216 922.41 Funds 6/30/21
Capital Research & Management Co. (International Investors) 8.63 5,578,232 705.70 13F 3/31/21
Capital Research & Management Co. (World Investors) 7.34 4,739,936 599.65 13F 3/31/21
Marshall Wace LLP 4.30 2,776,467 351.25 13F 3/31/21
1919 Investment Counsel LLC 3.97 2,564,020 324.37 13F 3/31/21
Oracle Investment Management, Inc. 3.29 2,123,271 268.62 13F 3/31/21
RP Management LLC 3.27 2,111,111 267.08 13F 3/31/21
Eventide Asset Management LLC 3.12 2,015,000 254.92 13F 3/31/21
Wellington Management Co. LLP 2.81 1,815,354 229.66 13F 3/31/21
BlackRock Fund Advisors 2.63 1,696,530 214.63 13F 3/31/21
Ownership data is sourced through FactSet.

Stock Market Data

Data is being loaded...
Data is being loaded...
Data is being loaded...
Data is being loaded...
Market Data copyright © 2021 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, RTB=Real-Time BATS BZX Price/Quote; not sourced from all markets, RTN=Real-Time NASDAQ Basic+ Price/Quote; not sourced from all markets, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.